Health Care: Drugs

Enanta Pharmaceuticals Inc (ENTA: NASDAQ)

$40.62 0.52 | 1.3%
05/26/15 - 10:27 AM ET
Company Profile
Price and Volume
Recent Price 40.10
52 Week High 52.58
52 Week Low 30.13
Avg. Daily Vol. (Mil) 0.32
Beta (3 year) 0.36
Share Related Items
Mkt Cap (Mil) 749.55
Shares Out (Mil) 18.69
Float (Mil) 15.74
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 8.80
Current Ratio 9.00
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 6.70
Price/Sales 4.17
Price/Book 3.34
Price/Cash Flow 6.30
Per Share Data
Earnings 6.01
Sales 9.61
Book Value 12.00
Cash Flow 6.32
Business Summary
Enanta Pharmaceuticals Inc is a biotechnology company. It is engaged in the research and development of small molecule drugs for infectious diseases. The Company uses its chemistry-driven approach & drug discovery capabilities to develop its products.
General Information
500 Arsenal Street
Watertown, MA 02472
www.enanta.com
Industry : Drugs
Sector: Health Care
Employees: 52
CEO: Dr. Jay R. Luly
Short Interest
Current Month (Mil) 3.40
Previous Month (Mil) 3.32
Short Interest Ratio (Days) 10.50
Management Effectiveness
Return on Equity 51.60
Return on Assets 47.10
Return on Investments 51.60
Profitability
Gross Margin n.a.
EBIT Margin 81.70
Profit Margin 64.50

Portfolios with ENTA

Latest ENTA Headlines from TheStreet

More Financial News for ENTA

Press Releases for ENTA

See All Press Releases

Partner Headlines for ENTA

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter